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Abstract.  During extracellular matrix assembly, fibro- 
nectin (FN) binds to cell surface receptors and initi- 
ates fibriUogenesis. As described in this report,  matrix 
assembly has been dissected using recombinant FN 
polypeptides (recFNs) expressed in mammalian cells 
via retroviral vectors. RecFNs were assayed for incor- 
poration into the detergent-insoluble cell matrix frac- 
tion and for formation of fibrils at the cell surface as 
detected by indirect immunofluorescence.  Biochemical 
and immunocytochemical data are presented defining 
the minimum domain requirements for FN fibriUo- 
genesis.  The smallest functional recFN is half the size 
of native FN and contains intact amino- and carboxy- 
terminal regions with a large internal deletion spanning 
the collagen binding domain and the first seven type 
III repeats.  Five type I repeats at the amino terminus 
are required for assembly and have FN binding activity. 
The dimer structure mediated by the carboxy-terminal 
interchain disulfide bonds is also essential. Surprisingly, 
recFNs lacking the RGDS cell binding site formed a 
significant fibrillar matrix.  Therefore, FN-FN interac- 
tions and dimeric structure appear to be the major de- 
terminants  of fibrillogenesis. 
F 
IBRONECTIN (FN) t is a  major  component of verte- 
brate tissues.  FN, together with other glycoproteins 
and proteoglycans, forms a complex extracellular net- 
work that plays a crucial role in a wide variety of  developmen- 
tal and cellular processes including cell adhesion, migration, 
morphology,  differentiation,  and proliferation  (reviewed in 
McDonald,  1988; Ruoslahti,  1988; Mosher,  1989; Hynes, 
1990). At the molecular level, cell movement and behavior are 
mediated by FN fibrils extending between cells and to the sub- 
stratum.  Elaboration  of this  fibrillar  network involves in- 
teractions between FN and a variety of extracellular  matrix 
(ECM) molecules such as collagens and proteoglycans as well 
as with a number of different  cell surface receptors, par- 
ticularly integrins. This dynamic assembly process cannot be 
reproduced with purified matrix components. 
In the initial  stages of FN matrix assembly,  the temporal 
and spatial  order of association of cell surface molecules 
with extracellular  proteins must be well-orchestrated  in or- 
der to form a stable framework of FN fibrils. Subsequent in- 
teractions between matrix components at sites removed from 
the cell surface are probably involved in matrix accumula- 
tion and maintenance. As a complex, multi-component struc- 
ture,  the matrix does not readily lend itself to detailed mo- 
lecular analysis.  Consequently,  many studies  to date have 
focused on the FN domains required for the latter stages of 
assembly, namely, incorporation of FN into established ma- 
trices. Cells will assemble exogenously added FN into fibrils 
1. Abbreviationsusedin thispaper: DOC, deoxycholate; ECM, extracellular 
matrix; FN, fibronectin; pFN, plasma FN; recFN, recombinant  FN; RGDS, 
arg-gly-asp-ser cell binding  sequence; VT1, rat-specific antifibronectin  mAb. 
(Hayman and Ruoslahti, 1979; McKeown-Longo and Mosher, 
1983; Chernousov et al.,  1985; Millis et al., 1985; Guan et 
al.,  1990).  Proteolytic  fragments  containing  the  amino- 
terminal  region of FN bind saturably to confluent  mono- 
layers  of fibroblasts  and can inhibit  ECM assembly (Mc- 
Keown-Longo and Mosher,  1985; McDonald et al.,  1987; 
Allio and McKeown-Longo,  1988; Quade and McDonald, 
1988;  Barry  and  Mosher,  1989).  Inhibition  experiments 
have also been used to show a role for cell surface receptors. 
Reagents that block FN-cell interactions,  i.e., anti-integrin 
and anti-FN antibodies  and the arg-gly-asp-ser  cell binding 
sequence (RGDS)-containing  peptides,  inhibit  matrix  as- 
sembly in culture systems (Akiyama et al., 1987; McDonald 
et al.,  1987; Woods et al.,  1988; Fogerty et al.,  1990) and 
in vivo (Darribere et al., 1990). Finally, recombinant,  trun- 
cated polypeptides, lacking the amino-terminus  but contain- 
ing the cell binding  domain, are not incorporated into the 
matrix (Schwarzbauer  et al.,  1987). Although these studies 
implicate  the amino-terminal  region and the cell adhesive 
domain in ECM assembly, the complex nature of the matrix 
makes it difficult to define the activities  contributed to this 
process by these domains or to distinguish  between direct 
and indirect  roles for these and other regions  of FN. 
To determine the sites directly involved in FN fibrillogene- 
sis and matrix formation,  I have elected to use recombinant 
polypeptides to dissect the domains required for this assem- 
bly process. A simplified system has been developed to ana- 
lyze de novo assembly of s~reted recombinant FNs (recFNs) 
in the absence of significant  levels of other ECM proteins, 
thus, eliminating the complications inherent in formation of 
a complete matrix.  Two criteria were applied to determine 
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into the detergent-insoluble matrix fraction and formation of 
fibrils detectable by immunofluo~ce.  Recombinant poly- 
peptides possessing the appropriate combination of domains 
are assembled into a  fibrillar FN matrix.  The amino-termi- 
nai region is indeed essential for this process and contains 
a  site of direct FN-FN  interaction. In addition, the recom- 
binant polypeptides must be secreted as covalent disulfide- 
bonded dimers;  monomeric  polypeptides do not assemble. 
Interestingly,  recFNs  lacking  the  RGDS  cell  binding  se- 
quence are assembled, showing that this sequence is not es- 
sential for fibril formation. I propose that the two major steps 
in FN fibrillogenesis are intermolecular FN-FN  interactions 
mediated by the amino-terminus followed by the multimeri- 
zation of FN  dimers into fibrils. 
Materials and Methods 
cDNA Constructions 
The retroviral vector, pI.J (Schwarzbaner  et el.,  1989; Guan et el., 1990), 
was used for most of the constructions for expression.  Restriction and other 
enzymes were purchased from New  England Biolabs (Beverly, MA) or 
Boehringer-Mannheim Biochemicals (Indianapolis,  IN). The majority of 
the 5' untranslated sequence was removed from the rat cDNA by introducing 
a BamHI linker at a Hinfl site 20 bp upstream of the ATG (Patel et al., 
1987). For expression of the amino-terminal 70-kD fibrin/collagen binding 
fragment, a termination codon was inserted by adding an XbaI linker to a 
blunted PstI site at position  1810, located at the end of repeat I9.  The 
BamHI to XbaI fragment was cloned into SP73 (Promega-Biotech,  Madi- 
son, WI), then excised with BamHI and SalI, which is adjacent to the Xbal 
site.  The resulting 1.8-kb BamHI-SalI fragment was cloned directionally 
into pl.2. 
For construction of the larger recombinant FN eDNA encoding both 
the amino-terminal region and the carboxy-terminal  half of the molecule 
(recFN Ii-9/Cll0), a HindHI linker was added after the PstI site. To attach 
this to the rest of the molecule,  a HindHI linker was also ligated onto an 
EagI site located  at position 4070 in the rat cDNA.  This corresponds to 
the junction between EIIIB and repeat ms and, therefore, It-9/Cll0 cDNA 
lacks  residues  1810-4070 encoding the first seven type nl repeats.  The 
resulting amino acid sequence across  this junction is QPLQPKLGAVPP, 
where the underlined residues  were introduced by the HindIlI linker and 
the flanking amino acids are present in rat pFN. The carboxy-terminal  por- 
tion encoded the domains for binding to cells,  heparin, and fibrin, along 
with the V region for efficient secretion and the pair of cysteines to form 
the interchain disulfide bonds and in the recFNs is termed Cll0. The other 
alternatively spliced  regions, EIIIA and EIIIB,  were omitted from these 
constructions. The 5' end of the cDNA encoding ANS0 kD is located at po- 
sition 2400, and this recFN contains sequences from repeat 1II3 to the car- 
boxy terminus, including ERIB and the V region in the vector,  MSV-pLP 
(Schwarzbaner  et al.,  1989). 
AU deletions were made by using convenient restriction sites within the 
cDNA and were designed to remove individual or sets of repeats as units. 
For I1-4/Cl10 and Ii_s/C110, the HindHI linker was added at a HpaII site 
(position 680) or a XhoH site (840), respectively, and the resultant BamHI- 
HindlH fragment encoding either the first four or five type I repeats  was 
inserted in place of that encoding the 70-kD fragment (It-9). The amino 
acid  sequences  at  these  two  junctions  are  CTSRPKLG  for  I~-4 and 
SAGSPKLG for Ii-5 where underlined residues are encoded by the HindIII 
linker.  Two other variations of the amino-terminal region, Is-II2 (Is,6 + 
H~.2) and b-9, required the addition of the FN signal sequence at the 5' end. 
A 150-bp fragment extending from a Hinfl site 20 bp upstream of the ATG 
to a Baml-H linker inserted at a BstNI site at the end of exon 1 of the FN 
gene was subeloned between the BgllI and BamHI sites in SP73 to generate 
the vector, SP73-FS. This fragment encodes the FN signal and putative pro 
sequences along with the first  19 amino acids of the mature protein. A 
Baml-H linker chosen to maintain the correct reading frame was added to 
a blunted HpalI site (position 680) located between h  and Is and a HindHI 
linker was attached to a blunted BglII site between II2 and 17 at position 
1400. This 720-bp BamHI-HincUH fragment was ligated into SP73-FS cut 
with BamHI and HindlH.  From the resulting plasmid, a BglII-Hindm frag- 
ment containing sequences from the FN signal through II  2 was ligated to 
the Cll0 in the vector pLJ. b_9/Cll0 extends from the BglII site at 1,400 
to the HindIH site added at PstI 1810, and was inserted into SP73-FS and 
then cloned into pLl as for Is-II2/Cll0. 
Two mutations were made within the C110 region of the cDNA. Deletion 
of the 20 amino acid segment containing the carboxy-terminal  cysteines that 
form the interchain disulfide bonds has been described previously (Schwarz- 
bauer et ai., 1989). The segment encoding the RGDS cell binding peptide 
was removed using a HaeHI restriction site at 4840 and a Fnu4HI site at 
4860. An 8-mer BamHI linker was added to the HaeHI and a 12-mer BamHI 
linker to the Fnu4HI site. After ligation and insertion into the larger cDNA, 
the final construction deletes seven residues,  RGDSPAS, and replaces them 
with three new amino acids, GSA. 
Cells and Viruses 
SVT2 (SV40-transformed  3T3) and 92 cells were grown in DME plus 10% 
calf serum (Hycloue  Laboratories,  Logan,  Utah).  ~I'2 cells were  trans- 
fected  with recombinant retrovirai vectors and SVT2 cells were infected 
with recombinant  retroviruses as described previously (Schwarzbaner et el., 
1989). G418-resistant infectants were screened for expression of recombinant 
FNs by gelatin or heparin affinity chromatography and SDS-PAGE of meta- 
bolically  labeled  secreted  proteins.  For  infected  cell  clones  secreting 
recFNs,  the presence of the correct recFN cDNA was confirmed by South- 
eru analysis of isolated genomic DNA. The hybridoma cell line secreting 
the rat-specific anti-FN mAb, VT1, was kindly provided by Dr. K. Fukuda 
(University of Vermont) and was cultured in DME supplemented with 15% 
FCS (Hyclone Laboratories). 
Metabolic Labeling and Immunoprecipitations 
Cells were labeled with 35S-methionine (Dupont-NEN, Boston, MA) at 25 
#Ci/ml for 24 h in DME minus methioniue supplemented with unlabeled 
methioniue (1.5 #g/ml) and 10% calf serum. For some experiments,  serum 
was depleted of bovine pFN by gelatin-agarose  affinity chromatography. 
Conditioned medium was collected,  cells were lysed,  and deoxycholate- 
insoluble material was fractionated as described (Choi and Hynes,  1979; 
Schwarzbaner et ai.,  1989).  PMSE EDTA, iodoacetic  acid, and N-ethyl- 
maleimide (NEM) were added as protease inhibitors. DOC-insoluble mate- 
riai was recovered by centrifitgation  and solubilized in 1% SDS,  25 mM 
Tris-HC1, pH 8.0, 2 mM EDTA.  On average, 75% of the DOC-insoluble 
proteins were solub~  under these conditions. 
RecFNs were immunoprecipitated using a rabbit anti-rat pFN antiserum 
(Schwarzbauer  et el.,  1989), samples were eluted from protein A-agarose 
beads (Repligen, Cambridge, MA) by boiling in SDS electrophoresis sam- 
ple buffer, and samples were separated in a 5 % SDS polyacrylamide  gel ei- 
ther reduced, by adding DTT to 0.1 M, or nonreduced.  Gels were treated, 
and proteins visualized and quantitated as described (Schwarzbauer  et ai., 
1989). 
Immunofluorescence 
Rabbit anti-rot pF'N antiserum was passed over a rat pFN-Sepharose column, 
and antibodies were eluted with 0.23 M glycine, pH 2.6, and immediately 
neutralized with 1 M Tris-HC1, pH 8.8. These afffinity-purified antibodies 
exhibited lower background staining than the complete antiserum in immu- 
nofiuorescence  experiments,  but retained the ability to recognize human, 
mouse, and bovine FNs. Polyclonai antibodies were diluted 1:25 and culture 
supernatant from VTI hybridoma cells was used at a dilution of 1:10. 
SVT2 cells expressing various recFNs were cultured on glass coverslips 
until almost confluent, washed with PBS, and fixed with 3.7 % formaldehyde 
in PBS for 15 min at room temperature.  Coverslips  were washed several 
times with PBS and incubated with primary antiserum diluted in 2 % ovalbu- 
min in PBS in a moist chamber for 30 min at 37°C. Subsequent incubations 
were  with goat anti-mouse or goat anti-rabbit biotinylated IgG (BRL, 
Galthersburg, MD) diluted  1:100 in ovalbumin/PBS  followed by rhoda- 
miue-avidin (ICN Biochemicals,  Costa Mesa,  CA) or fluorescein-avidin 
(Cappel Laboratories, Malvern, PA) at 1:400 or 1:300, respectively. Cover- 
slips were washed three times with PBS between each incubation. A final 
wash with water was included prior to mounting in Fhiorsave (Calbiochem- 
Behring Corp., La JoHa, CA). Stained fibrils and cells were visualized with 
a Nikon Optiphot microscope with epifluorescence using a 40x phase/fluo- 
rescence objective.  Fibrils were photographed with Kodak Tri-X Pan 400 
black and white print film which was developed with Diafine developer, and 
prints were prepared with an Ilford rapid print processor. 
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Cell-conditioned medium was collected, clarified by centrifugation, and 
treated with collngennse (Colstridium histolyticum; Sigma Chemical Co., 
St. Louis, MO) at 60 U/ml in the presence of 2 mM PMSF and 0.5 mM 
NEM for 1 h at 37°C. Digestion was stopped by adding EDTA  to a final 
concentration of 10 raM, and samples were stored frozen  or used immedi- 
ately for immunoprecipitation or binding assays. Monolayers  were treated 
with collagenase  before  lysis  by incubating  with DME plus PMSF and NEM 
as for medium with 120 U collugenase  per ml of solution. Incubation was 
for 15 min at 37°C. EDTA  was added  and cells were washed twice with PBS 
and lysed with DOC as described above. 
Affinity Binding Assays 
Gelatin-ngarose and heparin-agarose (Sigma Chemical Co.) affinity chro- 
matography were performed batchwise by incubating 3SS-methionine-la- 
beled conditioned medium from SVT2 cells lines with resin at 4°C for 1-2 h 
with end-over-end mixing. Bound proteins were separated from unbound 
by centrifugation and washing twice with cold PBS. Bound proteins were 
eluted by boiling in SDS electrophoresis sample buffer minus DTT. 
Human pFN was purified from outdated plasma and rat pFN was purified 
from fresh plasma by gelatin-agarose  affinity chromatography (Engvall and 
Ruoslahti,  1977).  pFN was coupled to Sepharose (Pharmacia/LKB, Pis- 
cataway, NJ) following the manufacturer's recommendations. The batchwise 
FN-Sepharose incubation  conditions were essentially the same as above ex- 
cept that 100 tA packed beads containing 100 gg coupled human FN was 
incubated with 0.5 ml labeled medium. Although this represents an excess 
of coupled FN over labeled protein, binding of labeled recFNs was never 
quantitative. 
To assay the FN binding ability of reeFNs in the absence of other secreted 
or serum proteins, particularly mouse and bovine  FNs, cells were metaboli- 
cally labeled in serum depleted of bovine pFN, and recFNs were purified 
using the following  procedure.  35S-methionine-labeled conditioned  medium 
was  passed  through  a  gelatin-agarose  column  to  remove secreted  mouse FN 
and  other  gelatin  binding  proteins.  The  flowthrou~ fraction  was  put  over 
a  heparin-agarose  column, which was then  washed with PBS until  the 
counts went down to background  levels.  Heparin-bound proteins  were 
eluted  with  0.8  M  NaCl  in  20  mM  Tris-HCI,  pH  8.0,  2  mM  ED'I'A.  Fractions 
containing  the  highest  clams  were  pooled  and  dialyzed  into  PBS.  This  sam- 
ple  was centrifuged  to  remove insolubles  and  applied  to  a FN-Sepharose 
column, washed  with  PBS, and  eluted  with  4 M  urea/PBS.  Fractions  were 
counted and analyzed  after  electrophoresis  by fluorography  or by silver 
staining  (Merril  et  al.,  1984). 
Results 
A System for Dissecting FN Matrix Assembly 
ECM assembly is a multicomponent, dynamic process that 
involves both secreted and cell surface molecules. Dissection 
of this process has been hampered by the complexity of the 
interactions, so a simplified system was designed whereby a 
single component could be introduced by eDNA expression 
and its activity tested. To minimize the effects of endogenous 
FN and other ECM components on matrix formation, SV40- 
transformed  mouse  3T3  (SVT2)  ceils  were used  for these 
studies.  SVT2 cells synthesize and secrete reduced levels of 
most ECM  proteins,  including  FN  (Yamada  et  al.,  1976; 
Yamada and Kennedy, 1979; this report). As a consequence, 
these cells assemble  little,  if any, FN matrix.  Only a  very 
sparse, punetate pattern was observed after immunofluores- 
cent staining with polyclonal anti-FN antibodies (Fig.  1 A). 
However, upon addition of purified rat plasma FN (pFN) to 
the culture medium, SVT2 cells accumulated the exogenous 
FN  in the  form of fibrils  that were  detectable  with  a  rat- 
specific  anti-FN  mAb (VTI)  (Fig.  1  C).  Therefore,  these 
cells can bind rat FN and assemble it into fibrils at the cell 
surface. No fluorescent signal was detected on SVT2 cells in 
the absence of added rat pFN (Fig.  1 B). 
We have previously established that SVT2 cells will syn- 
Figure 1. Immunofluorescence staining of SVT2 cells. To examine 
the endogenous SVT2 FN matrix, cells were cultured  in medium 
containing FN-depleted calf serum and then fixed and stained with 
affinity-purified polyclonal anti-FN antibodies  (A). A few faint FN 
fibrils can be seen.  Similar  staining was observed when cells were 
cultured in serum containing calf pFN (data not shown). There was 
no staining  of SVT2  cells  with the  rat-specific  mAb,  VTI (B). 
When SVT2 cells  were incubated with rat pFN for 24 h before 
fixing, an extensive fibrillar  matrix of exogenous rat pFN was de- 
tected with the VT1 mAb (C). 
thesize and secrete eDNA-encoded FN polypeptides at rela- 
tively high levels and in the form of disulfide-bonded dimers 
(Schwarzbauer et al.,  1989). Together with the ability to as- 
semble  FN into fibrils in the absence of an extensive pre- 
existing matrix, this provides a simplified system for analysis 
of the function of recombinant and mutant FN polypeptides 
during ECM formation. 
Construction and Expression of  Recombinant 
FN Polypeptides 
Truncated "deminectins" dimeric polypeptides composed of 
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Figure 2.  Schematic diagram 
of  FN and recFNs exp~ssed in 
s'cr2 cells. The top diagram 
shows the structural organiza- 
tion of  FN. Domains for bind- 
ing fibrin, collagen, cells, and 
heparin  are  indicated as  are 
the first seven type 11I repeats, 
HI  (1-7). The  FN  dimer  is 
formed through the pair ofcys- 
teines at the very earboxy ter- 
minus (SS). FN is composed 
of three types of repeats, type 
I  (open  rectangles),  type  11 
(crosshatched triangles),  and 
type FII (stippled ovals).  The 
alternatively  spliced  type II1 re- 
peats,  EmA  and  EIIIB, are 
darkened. A third region of  al- 
ternative splicing, the V region 
(crossed box), has three differ- 
ent variants in rat FN,  Only 
one of these was used in these 
studies and is shown as V120. 
Eight recombinant versions of 
FN were constructed from rat 
FN  cDNAs and  the  repeats 
comprising each  are  shown. 
AN80 kD contains a contin- 
uous string of repeats, III3 to 
the carboxy  terminus. All other 
recFNs have repeats II1,_7 ddetcd. All are I~[IA-, VI20+. I1_9/Cl10, II_9/Cll0-RGDS, and I1_9/Cl10M are identical in the amino-terminal 
region (I)~) contai~ng six type I ~  Or(), two type II repeats (IIi.2), and three type I repeats (I7-9).  This segment is connected to the 
CII0 half of the molecule beginning with repeat I~. The deletions within CII0 of the RGDS and of the carboxy-terminal eysteines are 
indicated by solid triangles. The next four recFRS are identical in the Cll0 segment but differ within repeats 11-9. II-4/Cl10 and I1_5/Cl10 
contain the first folr and five type I repeats, respectively. The next four repeats, I5,6 and IIi.2 make up I5-II2/Cl10. The amino-terminus 
of I7-9/Cl10 is eonlpo~l of thn~ type I 1~ from the collagen binding domain. Each of the cDNAs was inserted into the retroviral 
vector, pLJ, and SVT2 cell lines ¢~)ressing these polypeptides were produced by infection with recombinant retroviruses. 
the carboxy-terminal half of FN, are not incorporated into 
the ECM (Schwarzbauer et al.,  1987), suggesting that se- 
quences within the amino-terminal half are required for in- 
corporation. Therefore, a  set of overlapping cDNAs  was 
constructed that contained part or all of the amino-terminal 
70-kD fibrin/collagen binding region spanning nine type I 
repeats and two type 11 repeats (I1_9). Fig. 2 illustrates some 
of  the rat recombinant polypeptides that have been expressed 
in SVT2 cells for these studies. All of these recFNs contain 
the carboxy-terminal half of FN, from repeat IIIs to the ter- 
mination codon.  This half of the molecule was given the 
name Cll0 to designate its carboxy-terminal location and its 
110 kD molecular mass. The alternatively spliced V120 seg- 
ment was also present in all cDNAs, as this region is required 
for efficient secretion of FN dimers (Schwarzbauer et al., 
1989). 
Two regions of FN implicated in matrix formation are the 
amino-terminal fibrin/collagen binding segment and the cell 
adhesive domain.  RecFN Ii_9/Cll0 contains both of these 
regions but has a large internal deletion of repeats 1111_7 and 
the collagen domain is directly connected to the cell binding 
domain (Fig. 2). The size difference  between this protein and 
native FN, 180 and 250 kD, respectively, enabled the separa- 
tion and unequivocal detection of recombinant polypeptides 
over the background of endogenous SVT2 proteins. ANS0-kD 
is a large fragment of FN, covering sequences from the end 
of repeat 1112 to the carboxy terminus. This recFN is simi- 
lar  to  Ii_9/Cll0  in  size,  but  it  lacks  an  intact  amino- 
terminus. 
To test the individual requirements for the fibrin and colla- 
gen domains or other segments of the amino-terminal re- 
gion, deletions of sets of repeating units were made within 
the cDNA. Deletion boundaries were designed to fall pre- 
cisely between  repeats  so  as  to  have minimal  disruptive 
effects on the folding of adjacent repeats. The resultant re- 
combinant polypeptides contain repeats 11-4, Ii-5, I5-112, and 
I7-9 directly connected to Cll0 and are about half the size of 
full length FN at 132,  138,  134, and 127 kD, respectively. 
In addition, two sites within the carboxy-terminal half were 
mutated to determine their involvement in fibrillogenesis. 
I~_9/Cll0-RGDS  lacks  the  four amino  acids,  RGDS,  that 
comprise the cell binding site in repeat 11L0. In L_9/Cll0M, 
the cysteines that form the interchain disulfide bonds were 
deleted, resulting in synthesis and secretion ofa monomeric 
recFN. 
The cDNAs were inserted into the retroviral vector, pLJ, 
and transfected into the ~2 packaging cell line. SVT2 cell 
lines producing recFNs were generated by infection with the 
recombinant retroviruses, selection with the antibiotic G418, 
and screening of cell-conditioned medium for presence of 
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creted  and  ECM-associated 
recFNs. Cells were metaboli- 
cally labeled with ~SS-methio- 
nine and aliquots of cell-con- 
ditioned medium (M) and the 
DOC-insoluble ECM fraction 
of the cell lysate (E) were im- 
munoprecipitated and electro- 
phoresed  after  reduction  of 
disulfide bonds with DTT.  En- 
dogenous SVT2 mouse FN is 
present  in both medium and 
matrix fractions (arrowhead). 
All recFNs  were secreted at 
levels higher than that of  SVT2 
FN  (arrows, lanes  M),  but 
only some of these polypep- 
tides  were  incorporated  into 
the ECM  (lanes E).  Similar 
levels of I~-9/C110-RGDS  were 
incorporated  into  the  matrix 
in the absence of calf serum 
pFN (-pFN). Molecular mass 
standards of 180 and 116 kD 
are  marked  (dashes at left). 
The locations of 84- and 58-kD 
standards are indicated to the 
left of sample I1-9. 
high levels of recombinant polypeptides. SVT2 cell clones 
expressing different recombinant versions of rat FN were 
compared for their ability to form a recFN matrix. 
Biochemical Analysis of ECM Components 
ECM components form an insoluble network that is resistant 
to detergent extraction. As a consequence, stably incorpo- 
rated molecules can be identified by cell lysis with buffered 
2 % deoxycholate (DOC) followed by isolation of the DOC- 
insoluble  fraction.  This  technique was  used to determine 
which of  the expressed recombinant polypeptides were func- 
tional  for  incorporation  into  the  ECM.  35S-Methionine- 
labeled  cells were lysed with  2%  DOC  in  buffer,  DOC- 
insoluble material was solubilized with SDS,  and samples 
were analyzed after immunoprecipitation with anti-FN an- 
tiserum.  Fig.  3  shows  the levels of secreted recFNs in the 
cell-conditioned medium (lanes M) and assembled polypep- 
tides in the ECM (lanes E). All recFNs were secreted at high 
levels relative to the SVT2 FN. The extent of incorporation 
of recFNs into the DOC-insoluble matrix fraction can be 
ascertained by comparing band intensities of recFN relative 
to SVT2 FN between medium and matrix samples. It is clear 
that only a subset of these proteins was capable of incorpora- 
tion into the ECM. More specifically, the equivalent propor- 
tions of I~_9/C110 in medium and ECM fractions shows that 
this recFN was fully competent for assembly.  Within this 
context, absence of the RGDS cell binding peptide did not 
seem to reduce incorporation. On the other hand, the amino 
terminus and the dimer structure are essential for assembly. 
Polypeptides lacking the amino-terminal fibrin/collagen do- 
mains (AN80 kD, data not shown) were excluded from the 
DOC-insoluble material.  Although II_dCll0M  contains the 
amino terminus,  the carboxy-terminai interchain disulfide 
bonds are absent and the monomeric form results in a greatly 
reduced proportion incorporated into the ECM.  The pres- 
ence of serum FN in the culture medium did not enhance the 
incorporation of recFNs into the matrix.  Identical results 
were obtained when cells were cultured in FN-depleted se- 
rum as shown for the II_9/Cll0-RGDS  recFN (Fig.  3, -pFN). 
The essential  site within the 70-kD  region was  further 
localized by expressing cDNAs with deletions within this re- 
gion. Ii_5/Cll0,  containing the amino-terminal first five type 
I repeats, was as active as I~_9/Cll0 in FN matrix assembly 
(Fig. 3). ECM incorporation was ablated by removal of re- 
peat  I5  from that  polypeptide (I~MCll0).  Thus,  the  first 
four type I repeats alone are insufi~cient for matrix assembly. 
This might suggest that 15 is a critical component of a func- 
tional recFN by containing an essential sequence involved in 
fibril formation. To determine whether 15 itself is the active 
site,  the recFN consisting of this  and the following three 
repeats, I5-II2/C110, was tested and found to lack the ability 
to be incorporated into the matrix (Fig. 3). These data sug- 
gest that an individual repeat is essential for fibril formation, 
but is itself insufficient for this activity. 
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and ECM-associated recFNs 
Molar ratios of 
RecFN/SVT2 FN 
Medium  ECM 
I1_9/C110  1  3.8  4.4 
2  1.5  1.4 
I1-9/C  110-RGDS  1  4.6  6.0 
2  2.8  3.1 
I1-9/C110M  1  5.1  1.4 
2  6.4  2.0 
Ii-dC110  1  3.2  0.9 
2  5.1  1.5 
I1-5/C110  1  3.8  5.8 
2  2.5  2.5 
RecFN and SVT2 FN levels in immunoprecipitates of medium and DOC-in- 
soluble (ECM) samples were determined by densitometric scanning of fluoro- 
grams. RecFN values were correctexi  for difference in size using 180,  138, 
132,  and 250 kD for I)_9/C110, I3_5/C110, Ii.dCll0,  and SVT2 FN,  respec- 
tively, and molar ratios of recFN to SVT2 FN were calculated for each sample. 
The results for two independently isolated clones expressing different levels of 
recFN are listed. Note the correspondence between medium and ECM ratios 
for 11_9/Cl10, II_9/Cll0-RGDS, and II_~/Cll0. 
To test whether the carboxy-terminal half of the molecule 
is required  for matrix incorporation,  the levels of amino- 
terminal  70-kD  (It-9) region  alone  in  the  DOC-insoluble 
fraction were determined. This recombinant fragment con- 
sists of type I  and II repeats with a  termination codon in- 
serted at the end of repeat 19.  Although this  fragment has 
collagen binding activity and can bind to confluent fibroblast 
monolayers (McKeown-Longo and  Mosher,  1985),  the de 
Figure 4. Quantitation of recFNs in the medium and matrix. Rela- 
tive amounts of recFN were determined by densitometfic scanning 
of fluorograms and normalization to endogenous FN in the same 
sample as in "lhble  I. The ratio of normalized recFNs in representa- 
tive ECM and medium samples was calculated and is shown here 
as a histogram. Values of 1.0 mean that the recFN was incorporated 
into the matrix, while values less than 1.0 indicate that the polypep- 
tide was not functional. 
Figure 5. Dimer repertoire of  recFNs. To determine the proportions 
of recFN homodimers and recFN-SVT2 FN heterodimers secreted 
into the medium (1-4) and incorporated into the matrix (2',3'), sam- 
pies were electrophoresed without reduction: (lane 1 ) SVT2; (lanes 
2 and 2') I1_5/Cl10; (lanes 3 and 3') I1_9/Cll0-RGDS; (lane 4) 11-9/ 
CI10M. The dimers are: (a) FN-FN; (b) recFN-FN heterodimers; 
(c)  I1_9/Cll0-RGDS homodimers  (lanes 3  and  3');  (d)  II-5/Cl10 
homodimers  (lanes  2  and  2');  and  (e)  monomers  of II-9/Cll0M 
(lane 4). Molecular mass markers of 360 and 180 kD are indicated 
at the fight. The band migrating at position d in the SVT2 medium 
sample (lane 1) is a background band of unknown origin. 
novo incorporation of newly synthesized rec70kD was negli- 
gible as determined by analysis of DOC-insoluble proteins 
(Fig. 3). Together with the fact that the carboxy-terminal half 
is incompetent independent of the amino-terminus, I  con- 
clude that at least two "domains" are required for stable for- 
marion of a  FN matrix. 
To compare directly the activities of different recFNs for 
fibril formation, levels of secretion and incorporation into 
DOC-insoluble material were quantitated.  Ratios of recFN 
to endogenous SVT2 FN in the same sample were calculated 
using densitometric data for medium and ECM fractions. 
Molar ratios for two independently isolated clones express- 
ing different levels of recFN are listed in Table I. Equivalent 
proportions of recFNs Ii_9/Cll0, I1_9/Cll0-RGDS, and IL-d 
Cll0 were present in the medium and DOC-insoluble ECM 
fractions, while the ECM levels of It-9/Cll0M  and It-4/Cll0 
were reduced significantly. The ECM to medium ratios of 
these  normalized  values  were  calculated  for  each  recFN 
(Fig.  4).  A  value of 1.0 means that equivalent proportions 
were present in matrix and medium and the recFN was as 
functional as endogenous FN. Values lower than 1.0 indicate 
that a recFN was only partially active or was excluded from 
the matrix. The results define a hierarchy of active proteins 
that fits with the qualitative data. It_9/Cll0,  I1_9/Cll0-RGDS, 
and  I1_5/Cl10 polypeptides,  with  values  approaching  1.2, 
were at least as active as endogenous FN for assembly (Fig. 
4). The others had values of 0.3 or less. Clearly, lack of ei- 
ther the interchain disulfide bonds or of repeats I1_5 greatly 
inhibits incorporation. 
Three types of FN dimers are secreted when rat FN cDNAs 
are  expressed in  SVT2  cells:  homodimers of two recom- 
binant polypeptides, heterodimers of one recFN and one en- 
dogenous SVT2 FN subunit (recFN-FN), and dimers of two 
endogenous FN molecules (Schwarzbauer et al.,  1989).  To 
determine the representation of recFN-FN heterodimers and 
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staining  of  recFN  fibrils. 
SVT2 cell clones secreting dif- 
ferent reeFNs  were analyzed 
for the presence of recFN fi- 
brils by indirect immunofluo- 
rescence using the rat-specific 
mAb,  VT1. Ii_9/Cll0 (A and 
B),  It-5/Cll0  (C),  and  II-9/ 
CI10-RGDS (D)  formed ex- 
tensive fibrils. I1-9/Cl10M (E) 
and I1-4/Cl10 (F) were nega- 
tive. Two fluors were used in 
these experiments: cells in A, 
B, D, and E were stained with 
rhodamine, and those in C and 
Fwith fluorescein.  Background 
staining of  cells by rhodamine- 
avidin is apparent in E. 
recFN  homodimers in  medium and  matrix fractions,  the 
dimer repertoire was  analyzed by electrophoresis of non- 
reduced  immunoprecipitates  of  cell  medium  and  DOC- 
insoluble samples (Fig. 5). SVT2 cell medium contained FN 
dimers only (lane 1, band a). In cells expressing recombinant 
polypeptides,  the  major  secreted  forms  were  the  recFN 
homodimers of Lg/Cll0-RGDS  (lane 3,  band c) and I1-5/ 
Cll0 (lane 2,  band d),  or recFN monomer in the case of 
It-9/Cll0M  (lane  4,  band  e),  but  recFN-FN  heterodimers 
(band b) and FN dimers (band a) are also visible in the medi- 
um samples.  In fact, homodimer levels exceeded heterodi- 
mers for all of the recFNs (data not shown).  More impor- 
tantly,  the matrix was also composed primarily of recFN 
homodimers (lane 2', band d and lane 3', band c). This was 
not unexpected considering that the levels of recFN were 
significantly higher than SVT2 FN in reduced samples (see 
Fig.  3 and Table I). Although heterodimers are present in 
the ECM samples, the predominance of recFN homodimers 
demonstrates that these polypeptides are functional indepen- 
dent of full-length SVT2 FN. Therefore, matrix assembly ac- 
tivity is inherent in their structure. 
FibriUogenesis by Recombinant l~bronectins 
The incorporation of large quantities of recombinant pro- 
teins into the DOC-insoluble cell fraction indicates that they 
exist as stable components of the matrix. However, this cell 
fractionation approach does not address the structure of the 
incorporated polypeptides. To determine whether the recFNs 
were assembled into fibrils, the ECM was examined by indi- 
rect  immunofluorescence  using  the  rat  specific  anti-FN 
mAb,  VT1,  to stain cell monolayers. The I1_9/Cl10 recFN 
was formed into dense fibrils at the cell surface (Fig. 6 A) 
and extending between cells (Fig. 6 B). This recFN is clearly 
competent for fibrillogenesis, ruling out a major role for re- 
peats Ult_7 in this system. No fibrils were detected in cul- 
tures synthesizing It-9/Cll0M  (Fig. 6 E) or in those lacking 
the  amino-terminal  80-kD  (AN80  kD)  (data  not  shown). 
Therefore, the amino-terminal region and the dimer struc- 
ture are essential for fibrillogenesis. 
Biochemical  comparisons  showed  that  I~_9/Cll0-RGDS 
was very efficiently  incorporated into the ECM. By immuno- 
fluorescence analyses, fibrils composed of this protein were 
Schwarzbauer Fibronectin  Matrix Assembly  1469 Figure 7. FN binding activity. Several reeFNs were tested for binding to FN-Sepharose. (.4) Labeled cell-conditioned media were incubated 
batchwise with human pFN-Sepharose. For direct comparison between bound (B) and supernatant (S) fractions, the supernatant was subse- 
quently incubated with either gelatin-agarose (SVT2 and I1-9/(2110) or heparin-agarose (It-,dCll0, Im_5/Cll0 and Is-II2/Cll0) to recover 
recFNs (arrows). Proteins were eluted from FN-Sepharose and the other affinity resins in equal volumes of SDS sample buffer.  Note that 
while SVT2 FN (arrowhead) is present in both bound and supernatant fractions, only two of the four recFNs, I1_9/Cl10 and II-5/Cl10 (ar- 
rows), were retained by the FN-Sepharose. (B) Medium containing Ii_9/Cll0 was treated with collagenase to degrade endogenous colla- 
gens and then incubated with human pFN-Sepharose. Medium containing the I1_5/Cl10 recFN was also treated with collagenase followed 
by incubation with gelatin-agarose to remove SVT2 FN (arrowhead) and finally incubated with rat pFN-Sepharose. Bound fractions from 
media with (+) and without (-) collagenase treatment are shown. The absence of  collagen has no negative effects on recFN (arrows)  binding 
to FN. Furthermore, removal of SVT2 FN does not hinder binding of I~_5/Cl10. Note the low level of collagens synthesized by these cells 
and visible in the It-5/CII0 (-) sample (*). (C) The II-5/Cl10 recFN was partially purified from metabolically labeled medium by gelatin 
and heparin affinity chromatography. The heparin eluate (S) was applied to a human FN-Sepharose column and flowthrough (FT), wash 
and eluted (E/-4) fractions were collected and analyzed. The amount of I~_5/Cl10 (arrow) is reduced in the flowthrough fraction and can 
be seen in the eluted fractions E2-4.  No other proteins,  labeled or unlabeled,  were detected in the eluted fractions. 
indeed  formed and detectable  (Fig.  6  D).  Again,  in agree- 
ment with biochemical data,  L_5/Cll0  formed an extensive 
fibrillar  network,  while  Ii_dCll0  appeared  totally  incom- 
petent (Fig. 6, C and F). Cells secreting I5-II2/Cl10 and 17-9/ 
Cll0  were also negative (data not shown). 
Together these results localize two sites that are essential 
for  efficient  FN  fibril  formation.  One  site  resides  within 
amino-terminal  repeats  I1-s and  the other  is the  interchain 
disulfide bond cysteines. The RGD cell binding peptide prob- 
ably plays a role in initiation of fibrillogenesis at the cell sur- 
face, but is not required for intermolecular interactions with- 
in fibrils away from the cell. 
The Amino-terminal Repeats Comprise 
a l~bronectin Binding Site 
A  matrix composed primarily of FN must require intermo- 
lecular FN interactions and cannot rely on associations me- 
diated by other ECM components for formation and stabil- 
ity. However, sites of FN-FN binding have not been precisely 
localized. Therefore, each of the recFNs was tested for bind- 
ing to FN coupled to Sepharose in a batchwise assay. Radio- 
labeled conditioned media were incubated with either rat or 
human FN-Sepharose.  Unbound material was subsequently 
incubated with heparin-agarose or gelatin-agarose to recover 
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teins were eluted from the respective resins in equal volumes 
of SDS electrophoresis sample buffer, and equivalent sam- 
pies were electrophoresed and compared. All samples con- 
tain the endogenous FN as an internal control. The data in 
Fig. 7 A clearly show that only some of these recombinant 
polypeptides can interact with FN.  Specifically,  It_9/Cll0 
and II_JCll0 are present in both bound (B) and supernatant 
(S) fractions, while I1_4/Cl10 and I5-II2/Cl10 are found en- 
tirely in the supernatant. Therefore, only those proteins con- 
taining  repeats  11-5 bound  to  the  FN-Sepharose  and,  by 
comparison  with  the  unbound  material,  only  a  fraction 
(~25 %) of the total recombinant and endogenous FNs was 
retained. RecFNs did not bind to Sepharose alone in parallel 
experiments. 
A role for collagen as a mediator of this interaction was 
tested by pretreating the conditioned medium with bacterial 
collagenase. In addition, FN dimers and recFN-FN hetero- 
dimers were removed from the L_JCll0 sample before in- 
cubating with FN-Sepharose. Comparison of the FN-bound 
fractions in Fig. 7 B shows that removal of these collagens, 
and of SVT2 FN for the I~_dCll0 sample, did not affect the 
quantity ofrecFN retained. Also note that SVT2 cells secrete 
relatively low levels  of collagens which can be seen in the 
untreated Ii_dC110 (-) sample. 
It might be argued that the observed binding of recFNs 
from cell conditioned medium was mediated by secondary 
interactions with other FN binding proteins or was apparent 
binding due to insolubility. To rule out these explanations, 
I~_JCll0,  Ix.4/Cll0,  and I5-II2/Cl10  recFNs were purified 
and reexamined by standard column chromatography. En- 
dogenous SVT2 FN and heterodimers of recFNs with SVT2 
FN were first removed by gelatin-agarose chromatography 
and a heparin-agarose column was used for partial purifica- 
tion. Proteins eluted from the heparin column were passed 
over a human FN-Sepharose column, and retained proteins 
were eluted with 4 M urea/PBS. The results obtained in this 
experiment were essentially  the same as those from the batch- 
wise assay (Fig. 7  C).  Ii_dCll0 bound to the FN affinity 
resin and was eluted in fractions E2--4. All other labeled and 
unlabeled proteins in the original sample were found in the 
flowthrough fraction (silver stain data not shown). L_dCll0 
and I5-II2/Cl10 were not retained by the FN-Sepharose col- 
umn (data not shown). This result suggests that a FN binding 
site is contained within an intact domain consisting of re- 
peats I~-5. Together with the data showing a role for this do- 
main in fibril formation, there is a strong correlation between 
FN binding activity and fibrillogenesis. 
Collagen Is Not Required for Recombinant FN 
Matn'x Incorporation 
Many of  the recFNs that were competent for ECM incorpora- 
tion and fibril formation contain part or all of the collagen 
binding domain previously characterized by proteolysis and 
affinity chromatography on gelatin-coupled resins. Each of 
these polypeptides was tested for the ability to bind to colla- 
gen by batchwise incubation with gelatin-agarose.  As ex- 
pected,  Lg/Cll0 and I7-9/Cl10  bound gelatin, while It-5/ 
CII0, I~_dCll0  and Is-II2/Cll0 did not (data not shown). 
That repeats  I7-9  conf-erred  gelatin-binding activity, while 
repeats I5-II2 did not, localizes the major binding site in the 
collagen domain to the type I repeats, in agreement with Ing- 
ham et al. (1989). 
Although no apparent correlation exists between collagen 
binding activity and matrix incorporation, it is important to 
rule out a role for collagen in recFN matrix assembly. Colla- 
genase treatment of cell-conditioned medium was used to 
identify secreted collagens and showed that SVT2 collagen 
levels  are  reduced compared to untransformed 3T3  cells. 
While collagens present at these low levels could perform 
catalytic or nucleation roles, they would not likely be able 
to play a  major structural role in  fibrillogenesis.  To test 
whether collagen is involved in mediating fibril formation by 
recFNs, monolayers were treated with collagenase before ly- 
sis with DOC and levels  of recFNs in the DOC-insoluble 
fractions from treated and untreated cells were compared. 
No differences in recFN quantities were seen,  suggesting 
that disruption of collagen connections in the ECM does not 
release these proteins (data not shown). However, the strong- 
est argument against a primary role for collagen is the inabil- 
ity of recFN I7_9/Cl10, which maintains full gelatin binding 
activity, either to form fibrils or to be detected in the DOC- 
insoluble fraction (Figs.  3 and 4). 
Discussion 
The assembly of FN dimers into higher order structures at 
the cell surface is a dynamic process that requires both cells 
and extracellular components. In this report, I have shown 
that recombinant FN polypeptides, containing only a subset 
of the binding domains found in full-length FN, are fully 
functional in matrix assembly and fibriUogenesis.  Retroviral 
vector-mediated expression of different versions of rat FN 
eDNA in transformed mouse SVT2  cells resulted in rela- 
tively high levels of secreted recFNs. Two assays were used 
to determine whether these recFNs were assembled into the 
matrix: incorporation into the DOC-insoluble cell fraction 
and detection of recFN fibrils by indirect immunofluores- 
cence. Because SVT2 cells synthesize and secrete only low 
levels of ECM molecules, including FN, this system requires 
de novo fibril assembly in the absence of an extensive pre- 
existing matrix. Furthermore, these assays require incorpora- 
tion of mass amounts of protein, enough to detect by immu- 
noprecipitation and immunofluorescence. 
Recombinant polypeptides were designed to include car- 
boxy-terminal sequences known to be required for dimer 
secretion (the alternatively spliced V region) and cell attach- 
ment (the cell binding domain). The first seven type 111 re- 
peats (1111_7) were deleted to generate a polypeptide distinct 
in size from endogenous SVT2 FN. A  180-kD  recFN, 11-9/ 
C110, was constructed from this combination of domains to- 
gether with the amino-terminal fibrin/collagen binding re- 
gion. Expression of this eDNA resulted in formation of a 
dense  fibrillar matrix  of I1_9/Cl10 surrounding  the  cells. 
This model system was used to determine the regions of FN 
involved in FN matrix assembly and fibrillogenesis. Of the 
eight recombinant  polypeptides  examined, three accumulated 
at the cell surface at high levels and in the form of fibrils. 
One feature of FN that is absolutely required for fibrillo- 
genesis is the disulfide-bonded  dimer structure. The carboxy- 
terminal cysteines were deleted from the eDNA to generate 
a monomeric recFN, 11_9/Cl10~. This polypeptide was in- 
capable of forming fibrils. This seems opposed to the results 
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monomeric FN fragments to fibroblast monolayers (Cher- 
nousov et al.,  1985;  McKeown-Longo and Mosher,  1985; 
Quade and McDonald,  1989).  However,  their assays were 
designed to measure incorporation into preexisting matrices. 
The system described in this report requires de novo assembly 
of recFNs into fibrils independent of other matrix compo- 
nents. The results obtained with the monomeric recFN, I1-9/ 
Cll0M, demonstrate that, along with any domain(s) involved 
in the intermolecular interactions within the fibrils, the func- 
tional recFNs must also possess a dimeric structure to prop- 
agate the multimeric fibrillar network. 
Previous work in this system with shorter recombinant 
FNs  (deminectins)  demonstrated that the  amino-terminal 
half of the protein was necessary for matrix incorporation 
(Schwarzbauer et al., 1987). By extending the FN sequence 
toward the 5' end of the gene, I found that domains as close 
to the amino terminus as the collagen binding site, repeats 
17-9, were incapable of supporting matrix formation. Clearly, 
from the results with the Ii_dC110 recFN, a site within the 
amino-terminal 247 amino acids is essential for this func- 
tion. I1_5/Cl10 was active in all assays, ECM incorporation, 
fibril formation, and FN binding. Related recFNs containing 
Is but lacking the first four type I repeats (Is-II2/Cll0) and 
containing the first four but lacking 15 (I1_4/C110) were inac- 
tive. Therefore, although repeat I5 is necessary for these ac- 
tivities, it alone is not sufficient  and requires flanking repeats. 
One plausible interpretation of these results is that an intact 
amino-terminal domain containing repeat I5 is involved in 
both FN binding and fibrillogenesis. Subtle defects in the 
overall conformation and folding or in the proximity of re- 
peats within this globular domain in the absence of repeat 
15 cannot be ruled out. However,  deletion boundaries coin- 
cide precisely with the inter-repeat junctions so as to mini- 
mize conformational effects.  In  addition,  the recFNs  are 
synthesized and secreted at quite high levels,  suggesting no 
disruption of the secretory process due to improper folding. 
Deletion of the cell binding RGDS tetrapeptide from Ii-9/ 
C110 had no effect on the overall incorporation of recFN into 
the matrix and had only a slight effect on fibrillogenesis. Fi- 
brils still formed but they had a more punctate appearance 
than when the RGDS sequence was present.  Possibly,  fre- 
quent contacts with the otsBl integrins on the cell surface 
facilitate formation of stable, extended fibrils, while the in- 
termolecular interactions within the matrix are not directly 
affected by the absence of this sequence. It seems likely that 
the presence of low levels of SVT2 cell FN (containing the 
RGDS sequence) aids in nucleation of fibril formation even 
though these molecules cannot serve a major structural role. 
Nucleation might also rely on the interactions of other-FN 
domains with the cell surface, either complementing or re- 
placing the cell binding region. We are in the process of fur- 
ther characterizing the roles of cell surface molecules in ini- 
tiating matrix formation. 
It follows from the results with recFN II_9/Cll0-RGDS 
that cell binding and fibrillogenesis are sequential, separable 
steps in the process of  matrix assembly. This hypothesis pro- 
vides an explanation for the inhibition of matrix assembly by 
anti-integrin antibodies and by antibodies against the cell 
binding domain of FN (McDonald et al., 1987; Woods et al., 
1988; Akiyama et al., 1989; Fogerty et al., 1990). The anti- 
bodies would not directly affect FN fibrillogenesis, but would 
rather interfere with associations between FN fibrils and the 
cell surface. At high concentrations of antibody, FN-integrin 
interactions would be blocked and FN accumulation would 
be decreased. Similarly, a threshold level of cell surface in- 
tegrins is necessary for deposition of a FN matrix by CHO 
cells (Giancotti and Ruoslahti,  1990). 
The existence of a FN matrix assembly domain has been 
predicted by a number of approaches. Two amino-terminal 
proteolytic fragments, the 29-kD fibrin and the 70-kD fibrin/ 
collagen binding segments, can bind to cell monolayers, can 
be crosslinked into the matrix, and, at high concentrations, 
can inhibit matrix assembly (McKeown-Longo and Mosher, 
1985; McDonald et al., 1987; Quade and McDonald, 1988; 
Barry and Mosher, 1989). In accordance, I have demonstrated 
a requirement for amino-terminal repeats 11-5 in FN fibrillo- 
genesis. In addition, a monoclonal antibody that recognizes 
repeats IdIIIl can block matrix assembly (Chernousov et 
al.,  1987; Mosher et al.,  1990).  The  smallest functional 
recFN,  Ii_dCll0,  lacks  both of these  repeats,  suggesting 
that this region is not involved in fibrillogenesis. However, 
it is likely that multiple sites along the FN molecule are in- 
volved in interactions either with other FNs or with other 
matrix and/or cell surface proteins. 
The results presented here localize a FN binding site to 
amino-terminal repeats  Ii-5. Under  the  FN-binding assay 
conditions used, only 25 % of the FN bound to the human 
pFN-Sepharose resin.  This is not due to cross-species in- 
compatibility, as  identical results  were obtained  with rat 
pFN-Sepharose. Apparently, the interaction mediated by the 
amino-terminal domain is weak and the proteins dissociate. 
Cooperation among multiple sites could serve to increase the 
avidity of FN for itself and would strengthen and stabilize 
the associations. Interactions between fragments containing 
the amino-terminal 29-kD and the carboxy-terminal heparin 
domain as well as homophilic associations between carboxy- 
terminal heparin and fibrin binding fragments have been re- 
ported (Homandberg and Erickson,  1986).  Furthermore, a 
60-kD proteolytic fragment containing the collagen-binding 
domain has been shown to have FN binding activity (Ehris- 
man et al., 1981, 1982). Additional sites of interaction might 
exist in other regions of FN, for example, the cellular FN- 
specific alternatively spliced EIIIA and EIIIB repeats or a 
segment containing repeats Ig/IIL.  Several approaches are 
currently being used to test other recombinant polypeptides 
for the ability to interact with FN. 
I have shown that FN fibrils form via interactions between 
FN molecules, and multimerization relies on the FN dimer 
structure. The cell binding domain and the RGD sequence 
apparently initiate fibrillogenesis and stabilize the fibrils by 
interactions with cell surface integrins. Previous work has 
suggested the presence of a "matrix assembly receptor" that 
binds to the amino terminus of FN and initiates fibril forma- 
tion (McKeown-Longo and Mosher,  1985).  Although my 
results do not preclude the existence of such a receptor, they 
do provide an alternative model. Matrix assembly could pro- 
ceed through three  stages,  initiation,  fibrillogenesis,  and 
stabilization.  Upon secretion, FN dimers bind to the cell 
surface through the RGD sequence and other domains that 
interact with receptors. Due to the antiparallel orientation of 
the  FN  subunits within the dimer (Skorstengaard et  al., 
1986),  the subunits are poised for head-to-tail associations 
with other FN dirners. Fibrillogenesis ensues where fibrils 
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dimers. Subsequent lengthening and bundling of fibrils gen- 
erates a linear and branched extracellular  network. Matrix 
stabilization then proceeds via a concerted set of  interactions 
between FN fibrils and between FN and the cell  surface. 
Clearly, other ECM components are involved in this process 
but their roles have not yet been defined. This system will 
prove useful for determining the functions of other regions 
of  FN and other ECM proteins, such as proteoglycans, in this 
complex process. 
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